Gynecological laparoscopic surgery patients
Conditions
Interventions
Sevoflurane + TAP group (Group CT):Both sides were given 0.33% ropivacaine 20ml for TAP
Sevoflurane + Sufentanil group (Group CS):0.5ug/kg sufentanil was given intravenously 3min before skin excision
Sevoflurane + TAP group+Sufentanil group (Group TS):Both sides were given 0.33% ropivacaine 20ml for TAP and 0.5ug/kg sufentanil was given intravenously 3min before skin excision
Sponsors
Affiliated Hospital of North Sichuan Medical College
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. ASA I-II; 2. Age 18-65; 3. 100 patients with gynecological laparoscopic surgery were selected.
Exclusion criteria
Exclusion criteria: 1. The patient has a history of cardiopulmonary disease; 2. Abnormal liver and kidney function; 3. Have a history of hypertension, diabetes and stroke; 4. Have a history of alcoholism and drug abuse; 5. Patients with acid-base electrolyte imbalance and blood coagulation disorder before operation; 6. Those who have recently taken drugs that affect the cardiovascular system and adrenergic response; 7. Pregnant patients; 8. Patients who are allergic to local anesthetics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| minimal alveolar concentration of blocking adrengic response(MACBAR);Heart rate(HR);Mean arterial blood pressure(MAP); | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative abdominal pain Visual Analogue Scale/Score(VAS); | — |
Countries
China
Contacts
Public ContactPingping Jiang
Affiliated Hospital of North Sichuan Medical College
Outcome results
None listed